ReviewFrontiers in cell and developmental biology2026
Advances in understanding the mechanisms underlying acquired resistance to third-generation tyrosine kinase inhibitors in non-small cell lung cancer.
Gu-Ha A-Lai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.